The new service monitors 37 types of alarms and 26 operating parameters to provide a status overview of the freezers.
Thermo Fisher Scientific’s addition of the Thermo Scientific Smart Connected Services for its wifi-connected Thermo Scientific TSX Series Ultra-Low Temperature (ULT) Freezers enhances the collection and monitoring of performance data in regard to sample and product protection.
The new service, launched in October 2020, monitors 37 types of alarms and 26 operating parameters to provide a status overview of the TSX Series ULT Freezers. The monitors and alarms include ambient and cabinet temperature, power failure, battery status, door ajar, connectivity signal, and filter efficacy.
Additionally, as part of the new service, Thermo Fisher’s technical experts will examine the collected data to pinpoint out-of-specification operation and offer laboratories reactive warnings and long-term maintenance recommendations.
"Maintaining sample safety and integrity is paramount for life science research and clinical laboratories, and ULT freezers are a critical component of that work," said Sue Lambert, senior director of services for Laboratory Products at Thermo Fisher Scientific, in an Oct. 5, 2020 company press release. "However, monitoring the performance of ULT freezers can be costly, lengthy, and resource-intensive. The new Smart Connected Services feature is designed to give our customers peace of mind that their systems are operating properly. This service helps us provide our customers with actionable intelligence in both a reactive and proactive manner to guide well-informed, timely decision-making to actively protect sample and product integrity."
Source: Thermo Fisher Scientific
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.